These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 9148862)
1. Molecular genetic analysis of TGF beta1 in breast cancer. Cardillo MR; Yap E; Castagna G J Exp Clin Cancer Res; 1997 Mar; 16(1):57-63. PubMed ID: 9148862 [TBL] [Abstract][Full Text] [Related]
2. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia. Cardillo MR; Yap E; Castagna G J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861 [TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study. Cardillo MR; Yap E J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study. Cardillo MR; Yap EP Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. Lücke CD; Philpott A; Metcalfe JC; Thompson AM; Hughes-Davies L; Kemp PR; Hesketh R Cancer Res; 2001 Jan; 61(2):482-5. PubMed ID: 11212236 [TBL] [Abstract][Full Text] [Related]
8. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799 [TBL] [Abstract][Full Text] [Related]
9. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers. Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559 [TBL] [Abstract][Full Text] [Related]
10. BIGH3 is overexpressed in clear cell renal cell carcinoma. Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339 [TBL] [Abstract][Full Text] [Related]
12. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300 [TBL] [Abstract][Full Text] [Related]
13. Localization of recognition site between transforming growth factor-beta1 (TGF-beta1) and TGF beta receptor type II: possible implications in breast cancer. Ivanović V; Demajo M; Todorović-Raković N; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Krtolica K; Veljković V; Prljić J; Dimitrijević B Med Hypotheses; 2004; 62(5):727-32. PubMed ID: 15082097 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
15. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer]. Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802 [TBL] [Abstract][Full Text] [Related]
16. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer. Brandt S; Kopp A; Grage B; Knabbe C Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217 [TBL] [Abstract][Full Text] [Related]
17. Determination of transforming growth factor beta 1 mRNA expression in breast carcinomas by in situ hybridization. Walker RA; Gallacher B J Pathol; 1995 Oct; 177(2):123-7. PubMed ID: 7490677 [TBL] [Abstract][Full Text] [Related]
18. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas. Fujiwara K; Ikeda H; Yoshimoto T Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer. Hazelbag S; Gorter A; Kenter GG; van den Broek L; Fleuren G Hum Pathol; 2002 Dec; 33(12):1193-9. PubMed ID: 12514788 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast. Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]